Factors Associated With Pre-hypertension Among Children With Type 1 Diabetes Mellitus

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

ACTIVE_NOT_RECRUITING

Total Enrollment

60 participants

Study Classification

OBSERVATIONAL

Study Start Date

2025-07-26

Study Completion Date

2026-08-05

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

blood pressure of diabetic patients will be measured

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

A Clinical Study of the Performance of a Glucose Blinding Protein-Based Continuous Glucose Monitor (GBP CGM)

NCT01469715

Type 1 Diabetes Mellitus

COMPLETED PHASE2

Validation of a 13C Glucose Breath Test Compared With the Euglycaemic Clamp Test

NCT04623320

Insulin Resistance Type 1 Diabetes

UNKNOWN

Feasibility and Effectiveness of Real-time, Remote Continuous Glucose Monitoring in Adolescents With Poorly Controlled Type 1 Diabetes

NCT04540536

Diabetes Mellitus, Type 1 Noncompliance, Patient

COMPLETED NA

Hormone Responses During Hypoglycemia and the Accuracy of Continuous Glucose Monitors

NCT00607139

Type 1 Diabetes

COMPLETED

Continuous Glucose Monitoring in Women With Type 1 Diabetes in Pregnancy Trial

NCT01788527

Type 1 Diabetics Who Are Pregnant or Planning Pregnancy

COMPLETED NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

All the study participants will be examined for assessment of the height and weight using calibrated equipment, Body Mass Index (BMI) calculated and plotted against percentiles,Blood Pressure (BP) Measurement:

* BP will be measured using a calibrated, automated oscillometric device suitable for pediatric use.
* Appropriate cuff size will be used based on mid-arm circumference.
* Blood pressure will be measured in the non-dominant arm.
* BP will be measured three times on at least two different occasions, after 5 minutes of rest, in a seated position.
* The average of the readings will be recorded.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Hypertension

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_CONTROL

Study Time Perspective

PROSPECTIVE

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

blood sampling

blood samples will be taken to discover if there is hyperlipedemia,hyperthrodism or acute kidney injury

Intervention Type PROCEDURE

• BP will be measured using a calibrated, automated oscillometric device suitable for pediatric use.

All the study participants will be examined for assessment of the height and weight using calibrated equipment, Body Mass Index ,blood pressure will be measured.

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Children and adolescents aged 6 - 18 years, diagnosed with T1DM for at least 1 year and attending the Pediatric diabetes clinic at Sohag University Hospital will be included as cases.

Exclusion Criteria

Children and adolescents with T1DM associated with autoimmune hypothyroidism or celiac disease and those who had received any form of corticosteroids therapy for any reason in the last 6 months will be excluded.

\-

Minimum Eligible Age

6 Years

Maximum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes